Below are the most recent publications written about "Withholding Treatment" by people in Profiles.
-
Segan L, Kistler PM, Nanayakkara S, Taylor A, Hare J, Costello B, Chieng D, Crowley R, William J, Sugumar H, Cho K, Voskoboinik A, Ling LH, Nderitu Z, Azzopardi S, Curtin A, Premaratne M, McLellan AJ, Mariani J, Morton JB, Lee G, Joseph S, Reid C, Kaye DM, Kalman JM, Prabhu S. Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial. Eur Heart J. 2026 Jan 07; 47(2):250-262.
-
Islam JY, Hathaway CA, Hume E, Turner K, Hallanger-Johnson J, Tworoger SS, Camacho-Rivera M. Characteristics of Patients With Cancer and COVID-19 Who Discontinued Cancer Treatment. JAMA Netw Open. 2024 05 01; 7(5):e2411859.
-
Dworetz AR, Natarajan G, Langer J, Kinlaw K, James JR, Bidegain M, Das A, Poindexter B, Bell EF, Cotten CM, Kirpalani H, Shankaran S, Stoll BJ. Withholding or withdrawing life-sustaining treatment in extremely low gestational age neonates. Arch Dis Child Fetal Neonatal Ed. 2021 May; 106(3):238-243.
-
DeMartino ES, Sperry BP, Doyle CK, Chor J, Kramer DB, Dudzinski DM, Mueller PS. US State Regulation of Decisions for Pregnant Women Without Decisional Capacity. JAMA. 2019 04 23; 321(16):1629-1631.
-
DeMartino ES, Braus NA, Sulmasy DP, Bohman JK, Stulak JM, Guru PK, Fuechtmann KR, Singh N, Schears GJ, Mueller PS. Decisions to Withdraw Extracorporeal Membrane Oxygenation Support: Patient Characteristics and Ethical Considerations. Mayo Clin Proc. 2019 04; 94(4):620-627.
-
James J, Munson D, DeMauro SB, Langer JC, Dworetz AR, Natarajan G, Bidegain M, Fortney CA, Seabrook R, Vohr BR, Tyson JE, Bell EF, Poindexter BB, Shankaran S, Higgins RD, Das A, Stoll BJ, Kirpalani H. Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr. 2017 11; 190:118-123.e4.
-
DeMartino ES, Wordingham SE, Stulak JM, Boilson BA, Fuechtmann KR, Singh N, Sulmasy DP, Pajaro OE, Mueller PS. Ethical Analysis of Withdrawing Total Artificial Heart Support. Mayo Clin Proc. 2017 05; 92(5):719-725.
-
Leger P, Chirwa S, Turner M, Richardson DM, Baker P, Leonard M, Erdem H, Olson L, Haas DW. Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race. Pharmacogenet Genomics. 2016 10; 26(10):473-80.
-
Shaw KM, Gallek MJ, Sheppard KG, Ritter L, Vento MA, Asai SM, Nakagawa K. Ethnic Differences in Withdrawal of Life Support After Intracerebral Hemorrhage. Hawaii J Med Public Health. 2015 Jun; 74(6):203-9.
-
Buchhalter LC, Ottenberg AL, Webster TL, Swetz KM, Hayes DL, Mueller PS. Features and outcomes of patients who underwent cardiac device deactivation. JAMA Intern Med. 2014 Jan; 174(1):80-5.